Cigarette Sales Up in U.S. for the First Time in 20 Years

New Warranty, Rebate Programs Put Spotlight on Value in Lung Cancer

Atezolizumab Approved for Adjuvant NSCLC Therapy for Patients with Stage II-IIIA Disease, PD-L1 ≥ 1%

Ticiana Leal, MD, Moves to Emory University School of Medicine

First New Second-line Therapy for SCLC in Australia in 20 Years

Sotorasib Scores Second-line Approval in Canada

Prof. Fabrice Barlesi Appointed Chief Executive Officer of Gustave Roussy for a Term of 5 years

David R. Gandara, MD, Appointed Chief Medical Officer (CMO) of the International Society for Liquid Biopsy (ISLB)

Narjust Duma Moves to Dana-Farber Cancer Institute

Peter Bach, MD, is the New Chief Medical Officer at Delfi Diagnostic

Joshua Bauml, MD, moves to The Janssen Pharmaceutical Companies of Johnson & Johnson

Jean-Charles Soria, MD, PhD Joins Amgen